Polynucleotide Injection (Polydexoyribonucleotide Sodium)

Adult administration

Inject 1 vial daily intramuscularly or subcutaneously.

This drug should not be used in patients who have allergic reactions to the active ingredient or the included ingredients. If any allergic symptoms or hypersensitive reactions occur while using this drug, usage should be immediately discontinued and appropriate treatment should be sought. No specific interactions between this drug and other medications are known. A study conducted over 6 years involving 609 individuals in the region reported rare side effects such as itching, rash, pharyngalgia, vomiting, leukopenia, abdominal pain, diarrhea, and nausea after using this drug. However, serious side effects or unexpected adverse reactions have not been detected. Additionally, no side effects have been confirmed to occur more frequently in comparison to other medications.

Mild side effects

• Itchy rash
• pharyngalgia
• vomiting
• leukopenia
• abdominal pain
• diarrhea
• nausea

This drug should be stored in a sealed container to prevent air or moisture from entering, and it is recommended to store it at a temperature between 1 to 30 degrees Celsius at room temperature. This storage method helps maintain the drug's effectiveness for a longer time.

Appearance

A colorless, transparent liquid packaged in a colorless, transparent vial.

Package unit

3 milliliters/box [(3 milliliters/vial x 1)], 3 milliliters/box [(3 milliliters/vial x 3)], 3 milliliters/box [(3 milliliters/vial x 5)], 3 milliliters/box [(3 milliliters/vial x 10)]